Gelonghui September 27?Kehua Biology (002022.SZ)Investor interaction platform said that the company currently does not have dengue virus NSI antigen reagent products, and the company's holding subsidiary Tianlong Company has related products based on fluorescent PCR technology to detect dengue virus nucleic acid.
科华生物(002022.SZ)：子公司有基于荧光PCR技术检测登革热病毒核酸的相关产品
Kehua Biotech (002022.SZ): The subsidiary has products related to the detection of dengue virus nucleic acid based on fluorescence PCR technology
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.